Article metrics

Concise report
Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial

 

Online download statistics by month:

Online download statistics by month: September 2015 to March 2024

AbstractFullPdf
Sep 2015868261571
Oct 2015178165194
Nov 2015654180443
Dec 2015263141171
Jan 201699164141
Feb 2016120137133
Mar 20161129287427
Apr 2016633219239
May 2016369141119
Jun 201619314996
Jul 20161627770
Aug 201610510978
Sep 2016939775
Oct 201610710197
Nov 2016969367
Dec 2016836959
Jan 20178510285
Feb 2017246542
Mar 2017279463
Apr 2017910633
May 20171315290
Jun 2017379356
Jul 20171049735
Aug 201710510034
Sep 20171109639
Oct 201712011751
Nov 2017958537
Dec 2017897537
Jan 201811811755
Feb 20181029154
Mar 201811110046
Apr 20181098529
May 201816514784
Jun 2018957840
Jul 2018836727
Aug 2018837541
Sep 2018938929
Oct 2018505028
Nov 20181019244
Dec 2018686635
Jan 2019635745
Feb 2019686764
Mar 2019817043
Apr 20191038267
May 2019847745
Jun 2019624646
Jul 2019665758
Aug 2019675847
Sep 2019604636
Oct 2019666139
Nov 2019777053
Dec 2019675930
Jan 2020897235
Feb 2020816536
Mar 2020585027
Apr 2020696539
May 2020745835
Jun 2020615452
Jul 2020787553
Aug 2020575548
Sep 2020797236
Oct 2020816553
Nov 2020615055
Dec 2020393427
Jan 2021595528
Feb 2021544853
Mar 2021646231
Apr 2021343024
May 2021403627
Jun 2021535334
Jul 2021444424
Aug 2021282729
Sep 2021434322
Oct 2021635342
Nov 2021584963
Dec 2021474740
Jan 2022313124
Feb 2022464536
Mar 2022858151
Apr 2022504537
May 2022736741
Jun 2022736753
Jul 2022656535
Aug 2022554827
Sep 2022474930
Oct 2022495131
Nov 2022353529
Dec 2022544825
Jan 2023675620
Feb 2023777315
Mar 2023554918
Apr 2023574839
May 2023484434
Jun 2023242010
Jul 2023474428
Aug 2023342927
Sep 202327226
Oct 202311211213
Nov 202320320318
Dec 2023867219
Jan 2024544021
Feb 2024553518
Mar 2024594333
Total1109481636318